JP3064532B2 - Antifungal substance Mer-WF5027-II - Google Patents

Antifungal substance Mer-WF5027-II

Info

Publication number
JP3064532B2
JP3064532B2 JP20611491A JP20611491A JP3064532B2 JP 3064532 B2 JP3064532 B2 JP 3064532B2 JP 20611491 A JP20611491 A JP 20611491A JP 20611491 A JP20611491 A JP 20611491A JP 3064532 B2 JP3064532 B2 JP 3064532B2
Authority
JP
Japan
Prior art keywords
mer
antifungal
antifungal substance
iib
iia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP20611491A
Other languages
Japanese (ja)
Other versions
JPH0525160A (en
Inventor
裕之 千葉
憲夫 柴本
吉雄 渡辺
玲 金戸
武男 吉岡
俊彦 熊本
浩史 西田
六郎 岡本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mercian Corp
Original Assignee
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mercian Corp filed Critical Mercian Corp
Priority to JP20611491A priority Critical patent/JP3064532B2/en
Publication of JPH0525160A publication Critical patent/JPH0525160A/en
Application granted granted Critical
Publication of JP3064532B2 publication Critical patent/JP3064532B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】本発明は新規な抗真菌性物質に関し、さら
に詳しくは、それぞれ下記式
[0001] The present invention relates to novel antifungal substances, and more specifically,

【0002】[0002]

【化5】 Embedded image

【0003】及び[0003] and

【0004】[0004]

【化6】 Embedded image

【0005】で示される抗真菌性物質Mer‐WF50
27−IIA及び−IIB並びにそれらの製造法に関す
る。
The antifungal substance Mer-WF50 represented by
27-IIA and -IIB and methods for their production.

【0006】抗真菌性物質として、従来、アンホテリシ
ンB、グリセオフルビン、ポリオキシン、バリダマイシ
ン等の物質が知られているが、これら既知の抗真菌性物
質は毒性、薬効、薬剤耐性等において未だ充分であると
は言えない。
As antifungal substances, substances such as amphotericin B, griseofulvin, polyoxin, and validamycin have been known. However, these known antifungal substances are still insufficient in toxicity, efficacy, drug resistance and the like. I can't say.

【0007】本発明者らは今回、神奈川県平塚市の土壌
から分離したアスペルギルス属に属する或る種の菌株
が、抗真菌活性を有ししかも毒性の低い上記式(I)及
び(II)で示される新規な抗真菌性物質Mer‐WF
5027−IIA及び−IIBを生産することを見い出
し本発明を完成するに至った。
The present inventors have now found that certain strains belonging to the genus Aspergillus isolated from soil in Hiratsuka-shi, Kanagawa Prefecture have the antifungal activity and low toxicity described in the above formulas (I) and (II). Novel antifungal substance Mer-WF shown
The present inventors have found that 5027-IIA and -IIB are produced, and have completed the present invention.

【0008】上記式(I)の抗真菌性物質Mer−WF
5027−IIAと上記式(II)の抗真菌性物質Me
r−WF5027−IIBとは、結合異性体(Vale
nce isome)の関係にあり、これらの物質は
室温の溶液状態では、Mer−WF5027−IIAと
Mer−WF5027−IIBのモル比がほぼ5:1
(高速液体クロマグラフィーの結果による)の結合異性
体混合物として安定に存在しうる(以下、この混合物を
抗真菌性物質Mer−WF5027−IIという)。
The antifungal substance Mer-WF of the above formula (I)
5027-IIA and the antifungal substance Me of the above formula (II)
r-WF5027-IIB is a bond isomer (Vale
have a relationship of nce isome r), in these materials solution state at room temperature, the molar ratio of the Mer-WF5027-IIA and Mer-WF5027-IIB is approximately 5: 1
(Referred to as a result of high performance liquid chromatography) as a mixture of linked isomers (hereinafter, this mixture is referred to as an antifungal substance Mer-WF5027-II).

【0009】本発明の抗真菌性物質Mer‐WF502
7−IIA及び−IIBは、例えば、アスペルギルス属
に属する抗真菌性物質Mer‐WF5027−IIA及
び/又は−IIB生産菌を培地で培養し、培養物から抗
真菌性物質Mer‐WF5027−IIA及び/又は−
IIBを採取することにより製造することができる。上
記抗真菌性物質Mer‐WF5027−IIA及び/又
は−IIB生産菌としては、例えば、本発明者らが神奈
川県平塚市の土壌から分離したアスペルギルス・エスピ
ーMe 1207(Aspergillus sp.Me 1207)を
挙げることができる。この菌の菌学的性質は次のとおり
である。
The antifungal substance Mer-WF502 of the present invention
7-IIA and -IIB can be obtained by, for example, culturing an antifungal substance Mer-WF5027-IIA and / or -IIB-producing bacterium belonging to the genus Aspergillus in a culture medium, and extracting the antifungal substance Mer-WF5027-IIA and / or Or-
It can be produced by collecting IIB. Examples of the antifungal substance Mer-WF5027-IIA and / or -IIB producing bacteria include Aspergillus sp. Me 1207 (Aspergillus sp. Me 1207) which the present inventors isolated from soil in Hiratsuka-shi, Kanagawa. be able to. The mycological properties of this fungus are as follows.

【0010】(1)各種培地における生育形態 培養はすべて26℃で実施し、寒天平板培地での生育形
態を観察した。
(1) Growth form in various media All cultures were performed at 26 ° C., and the growth form on an agar plate medium was observed.

【0011】a)ツアペック寒天培地 生育は大変速く、ビロード状に生育するが、成熟すると
中心部が綿毛状となり多くの分生子柄を生じ、その先端
に分生子を着生する。コロニー表面の色調は初期、うす
黄色〜にぶ黄色であるが、成熟するとにぶ黄緑色〜暗い
黄緑色となる。コロニー裏面の色はうす黄色〜にぶ黄色
である。無色の浸出液滴が認められ、菌核の形成はな
い。閉子器(子のう胞子形成器官)の形成は認められな
い。
A) Tuapec agar medium The growth is very fast and grows in a velvety form. However, when matured, the central part becomes fluffy and many conidia are formed, and conidia are formed at the tips. The color tone of the colony surface is initially light yellow to dark yellow, but becomes yellowish green to dark yellow green when matured. The color of the back of the colony is light yellow to dark yellow. Colorless leach droplets are observed, with no sclerotium formation. No formation of milts (ascospore-forming organs) is observed.

【0012】b)麦芽エキス寒天培地 生育は大変速く、ビロード状に生育したコロニーは成熟
すると中心部が綿毛状に丈の高い分生子柄を生じ、多く
の分生子を着生する。コロニー表面の色は黄緑色〜にぶ
黄緑色を呈し、成熟するとにぶ黄緑色〜暗黄緑色とな
る。無色の浸出液滴が認められ、菌核及び閉子器の形成
は認められない。
B) Malt extract agar medium The growth of velvet-grown colonies is very rapid, and when matured, the confluent pattern is formed with a fluffy tall core when matured, and many conidia are formed. The color of the colony surface is yellowish-green to yellowish-green, and becomes mature yellowish to dark yellowish green when matured. Colorless oozing droplets are observed, with no formation of sclerotium and orchid.

【0013】(2)形態的性状 ツペック寒天培地での培養で、分生子柄の長さは2.
0〜2.5mmに達することもあり、その先端に分生子
を着生する。分生子柄の表面は粗面で多くの小突起を持
ち、先端部は球形〜長球形の頂のうがあり、その外側に
梗子を(5.0×8.5μ〜3.0×5.0μ)を付け
る。分生子(3.0〜4.5μ×4.0〜5.0μ)は
梗子の先端から発生し、放射状に広がり多くの分生子の
連鎖を形成する。成熟した頂頭の分生子魂は断裂して数
個の放散カラム状となる。
[0013] (2) in culture in the form Characteristics Tsu § Peck agar, length of conidiophores is 2.
It may reach 0-2.5 mm, and conidia are formed at its tip. The surface of the conidiophore is rough and has many small protrusions, and the tip has a spherical to long spherical apex, and the outer side of the conidia has a stalk (5.0 × 8.5μ to 3.0 × 5. 0μ). Conidia (3.0-4.5 μ × 4.0-5.0 μ) originate from the tip of the stalk and spread radially to form a chain of many conidia. The mature conidia at the apex rupture into several dispersing columns.

【0014】以上の性状から、本菌はアスペルギルス
(AspergilluS)属の菌であり、その形態か
らレパーとフェネルの「ザ・ジーナス・アスペルギル
ス」(1965)(Rper&Fennell“Th
e Genus Aspergillus”)を参考に
検討したところ麹菌類の一種と判定され、それに村上英
也らの「麹学」日本醸造協会(1986)も参考にして
調査したが、種を特定することはできなかった。従っ
て、本菌をアスペルギルス・エスピーMe1207(A
spergillu sp. Me1207)と命名
し、平成2年11月9日工業技術院微生物工業研究所に
寄託し、微工研菌寄第11848号 (FERM P−
11848)なる番号が付された。
[0014] From the above properties, this bacterium is a bacterium of Aspergillus (AspergilluS) genus, "The Genus Aspergillus" of its forms a fit Lee par and Fennell (1965) (R a per & Fennell "Th
e Genus Aspergillus "), it was determined to be a kind of koji mold, and it was also examined with reference to" Kojigaku "Japanese brewing association (1986) by Hideya Murakami et al., but the species could not be specified. Did not. Therefore, this bacterium was transformed into Aspergillus sp. Me1207 (A
spergillu sp. Me1207) and deposited on November 9, 1990 with the Research Institute of Microorganisms of the National Institute of Advanced Industrial Science and Technology.
11848).

【0015】しかし、抗真菌性物質Mer‐WF502
7−IIA及び/又は−IIB生産菌は上記アスペルギ
ルス・エスピーMe1207に限られるものではなく、
例えば、次のようにして見つけることができる他の生産
菌も同様に使用することができる。
However, the antifungal substance Mer-WF502
7-IIA and / or -IIB-producing bacteria are not limited to Aspergillus sp. Me1207,
For example, other producers that can be found as follows can be used as well.

【0016】キャンディダ・アルビカンスを検定菌とす
るバイオアッセイ寒天平板とバチルス・ズプチルスを検
定板とするバイオアッセイ寒天平板とを用い、穿孔法に
て土壌分離菌の培養濾液を検定し、前者の寒天平板に阻
止円を与え、更に後者の寒天平板において阻止円がほと
んど見えない培養濾液を与える土壌分離菌を検索する。
次に土壌分離菌の上記活性を有する培養濾液をミリポア
フィルター(DISMC−25cs;日本ミリポア・リ
ミテッド)で濾過し、高速液体クロマトグラフィーによ
り抗真菌性物質Mer−WF5027−IIA及び/又
は−IIBの標準サンプルと同一保持時間に検出され、
また上記培養濾液をセップパック(日本ミリポア・リミ
テッド)に吸着し、そのメタノール溶出液を薄層クロマ
トグラフィーで展開後、キャンディダ・アルビカンスを
検定菌とするバイオートグラフィーで検出することが
できれば、その菌は本発明の方法に用いることができる
抗真菌性物質Mer−WF5027−IIA及び/又は
−IIB生産菌であるということができる。
Using a bioassay agar plate with Candida albicans as a test bacterium and a bioassay agar plate with Bacillus subtilis as a test plate, the culture filtrate of the soil-isolated bacteria was assayed by the perforation method, and the former agar was used. The plate is given an inhibition circle, and the latter is searched for soil isolates that give a culture filtrate in which the inhibition circle is almost invisible on the agar plate.
Next, the culture filtrate having the above activity of the soil isolate is filtered through a Millipore filter (DISMC-25cs; Nippon Millipore Limited), and the antifungal substances Mer-WF5027-IIA and / or -IIB are standardized by high performance liquid chromatography. Detected at the same retention time as the sample,
The adsorbing the culture filtrate to a Sep Pack (Nippon Millipore Limited), after deployment of the methanol eluate by thin layer chromatography, if it is possible to detect bio-O over preparative chromatography to test bacteria of Candida albicans, the The bacterium can be said to be an antifungal substance Mer-WF5027-IIA and / or -IIB producing bacterium that can be used in the method of the present invention.

【0017】抗真菌性物質Mer‐WF5027−II
A及び/又は−IIBの培養のための培地としては、特
に制限はなく、従来からかびの培養に際して通常使用さ
れている培地を用いることができるが、例えば炭水化
物、窒素源、無機塩などの同化できる栄養源を含む培地
を使用することができる。例えばぶどう糖、グリセリ
ン、麦芽糖、しょ糖、糖蜜、デキストリン、澱粉などの
炭水化物や大豆油、落花生油、ラードなどの油脂、脂肪
類のごとき炭素源;ペプトン、肉エキス、大豆粉、綿実
粉、乾燥酵母、コーンスチープリカー、酵母エキス、脱
脂乳、カゼイン、硝酸ナトリウム、硝酸アンモニウム、
硫酸アンモニウムなどの窒素源;燐酸2カリウム、食
塩、炭酸カルシウム、硫酸マグネシウムなどの無機塩を
含む培地が使用でき、必要により微量金属例えばコバル
ト、マンガンなどを添加することができる。栄養源とし
ては、その他、抗真菌性物質Mer‐WF5027−I
IA及び/又は−IIB生産菌が利用して抗真菌性物質
Mer‐WF5027−IIA及び/又は−IIBを生
産するものであれば、いずれも使用でき、公知のかびの
培養材料はいずれも使用できる。また、加熱殺菌時及び
培養中における発泡を抑えるため、シリコン、植物油な
どの消泡剤を添加することもできる。
Antifungal substance Mer-WF5027-II
The medium for culturing A and / or -IIB is not particularly limited, and any medium conventionally used for mold cultivation can be used. For example, assimilation of carbohydrates, nitrogen sources, inorganic salts, etc. Media containing the available nutrients can be used. For example, carbohydrates such as glucose, glycerin, maltose, sucrose, molasses, dextrin, starch and the like, and oils and fats such as soybean oil, peanut oil, lard, and fats, carbon sources such as fats; peptone, meat extract, soybean powder, cottonseed powder, dried yeast , Corn steep liquor, yeast extract, skim milk, casein, sodium nitrate, ammonium nitrate,
A medium containing a nitrogen source such as ammonium sulfate; inorganic salts such as dipotassium phosphate, salt, calcium carbonate, and magnesium sulfate can be used, and trace metals such as cobalt and manganese can be added as necessary. Other nutrient sources include the antifungal substance Mer-WF5027-I
As long as the IA and / or -IIB producing bacteria are utilized to produce the antifungal substance Mer-WF5027-IIA and / or -IIB, any of them can be used, and any known mold culture material can be used. . In order to suppress foaming during heat sterilization and during culture, an antifoaming agent such as silicon or vegetable oil may be added.

【0018】かかる培地での該生産菌の培養は、通常、
約20〜約37℃の温度でpH4〜8において通気撹拌
下に好気的に行なうことができる。培養時間は大体48
〜100時間程度とすることができる。
The cultivation of the production bacterium in such a medium is usually carried out by
It can be carried out aerobically under aeration and stirring at a temperature of about 20 to about 37 ° C and a pH of 4 to 8. Culture time is about 48
It can be about 100 hours.

【0019】かくして、培養物中に蓄積された抗真菌性
物質Mer‐WF5027−IIA及び/又は−IIB
は主として菌体外に存在するので、有利には、培養後、
濾過、遠心分離、抽出などのそれ自体既知の分離法によ
って菌体を除去し、その濾液、上澄液、抽出液などによ
り回収することができる。
The antifungal substances Mer-WF5027-IIA and / or -IIB thus accumulated in the culture
Is mainly extracellular, so after culturing,
The cells can be removed by a separation method known per se such as filtration, centrifugation, or extraction, and the cells can be recovered from the filtrate, supernatant, extract, or the like.

【0020】回収はそれ自体既知の種々の方法で行うこ
とができ、とくに中性の有機物質の回収のためにしばし
ば利用される方法が有利に適用される。例えば、酢酸エ
チル、n-ブタノール、塩化メチレン、クロロホルム等
での溶媒抽出;活性炭、アンバーライトXAD(ローム
・アンド・ハース社製)、ダイアイオンHP-20(三
菱化成社製)等による吸着とメタノール水、アセトン水
等による溶出;セフアデックスG-10(ファルマシア
社製)、バイオ・ゲルP-2(バイオ・ラッド社製)等
によるゲル濾過;セルローズ、アビセルSF(アメリカ
ン・ビスコース社製)、シリカゲル、アルミナ等による
カラム法または薄層クロマトグラフィー;順相または逆
相高速液体クロマトグラフィー;アセトンなどの有機溶
剤添加による強制沈澱法;凍結乾燥法、などをそれぞれ
単独であるいは適宜組合せ、さらには場合によっては反
復使用することによって分離、精製することができる。
The recovery can be effected in various ways known per se, in particular those which are frequently used for the recovery of neutral organic substances. For example, solvent extraction with ethyl acetate, n-butanol, methylene chloride, chloroform, etc .; adsorption with activated carbon, Amberlite XAD (manufactured by Rohm and Haas), Diaion HP-20 (manufactured by Mitsubishi Kasei) and methanol Elution with water, acetone water or the like; gel filtration using Sephadex G-10 (manufactured by Pharmacia), Bio-Gel P-2 (manufactured by Bio-Rad), cellulose, Avicel SF (manufactured by American Viscose), Column method or thin layer chromatography with silica gel, alumina, etc .; normal phase or reverse phase high performance liquid chromatography; forced precipitation by addition of an organic solvent such as acetone; lyophilization method, etc., alone or in combination as appropriate. Some can be separated and purified by repeated use.

【0021】本発明により提供される抗真菌性物質Me
r−WF5027−IIは、下記第1表に示す液体培地
希釈法によるin vitro試験結果から明らかなとおり、真
菌に対する抗菌活性を示す。
The antifungal substance Me provided by the present invention
r-WF5027-II exhibits antibacterial activity against fungi, as is clear from the results of the in vitro test by the liquid medium dilution method shown in Table 1 below.

【0022】[0022]

【表1】 [Table 1]

【0023】*抗真菌性物質Mer−WF5027−I
Iを少量のメタノールに溶解した後に培地、イーストナ
イトロゲンベースグルコース(YNBG)で希釈し、2
00μg/mlを最高濃度とする2倍の希釈列を調製し
た。このものを96穴のマイクロタイターに0.1ml
ずつ分注した。検定菌はYNBGで前培養後、YNBG
で105CFU/mlとなるように希釈し、0.1mlを
マイクロタイターに加えた。マイクロタイタープレート
は35℃で48時間培養し、肉眼的に生育を認めない最
低の薬剤濃度をもってMICとした。
* Antifungal substance Mer-WF5027-I
After dissolving I in a small amount of methanol, the medium was diluted with yeast nitrogen-based glucose (YNBG),
A two-fold dilution series was prepared with a maximum concentration of 00 μg / ml. 0.1 ml of this in a 96-well microtiter
Was dispensed. The test bacterium is pre-cultured with YNBG, and then YNBG.
Was diluted to 10 5 CFU / ml with 0.1 ml, and 0.1 ml was added to the microtiter. The microtiter plate was cultured at 35 ° C. for 48 hours, and the MIC was defined as the lowest drug concentration at which growth was not visually observed.

【0024】以上述べたとおり、本発明のMer‐WF
5027−II物質は抗真菌活性を有しており、抗菌剤
として医薬、動物薬、農薬等の分野で使用することが期
待される。また、医薬、農薬等の製造中間体としても利
用することができる。
As described above, the Mer-WF of the present invention
The 5027-II substance has an antifungal activity and is expected to be used as an antibacterial agent in the fields of medicine, veterinary medicine, agricultural chemicals, and the like. It can also be used as an intermediate for producing pharmaceuticals, agricultural chemicals and the like.

【0025】次に実施例により本発明をさらに具体的に
説明する。
Next, the present invention will be described more specifically with reference to examples.

【0026】[0026]

【実施例1】アスペルギルス・エスピーMe1207
(FERM P-11848)の斜面培地(ポテトデキ
ストロース寒天培地)から一白金耳を50mlの種培地
(ジャガイモデンプン2%、グルコース1%、大豆粉2
%、リン酸1カリウム0.1%、硫酸マグネシウム0.0
5%、pH無調整)を入れた500ml容の三角フラス
コに接種し、28℃で3日振盪培養して種培養液を得
た。この種培養液の100mlを生産培地(ジャガイモ
汁:ジャガイモ200g/lの煮だし汁、ジャガイモデ
ンプン20g/l)5 lを含む10 l容ジャーファ
ーメンター(5基)に接種した。28℃、88時間通気
撹拌培養(通気量5 l/min.,撹拌300r.
p.m.)を行なった。培養終了後、約25 lの培養
液を濾過し、培養濾液23 lを得た。
Example 1 Aspergillus sp Me1207
(FERM P-11848) from a slant medium (potato dextrose agar medium) with a loop of 50 ml of seed medium (potato starch 2%, glucose 1%, soybean powder 2)
%, Potassium phosphate 0.1%, magnesium sulfate 0.0
(5%, no pH adjustment) was inoculated into a 500 ml Erlenmeyer flask, and cultured with shaking at 28 ° C. for 3 days to obtain a seed culture solution. 100 ml of this seed culture was inoculated into 5 l of 10 l jar fermenters containing 5 l of production medium (potato juice: boiled juice of 200 g / l potato, 20 g / l of potato starch). Aeration and agitation culture at 28 ° C. for 88 hours (aeration rate 5 l / min., Agitation 300 r.
p. m. ). After completion of the culture, about 25 l of the culture was filtered to obtain 23 l of the culture filtrate.

【0027】この濾液をダイアイオンHP-20(三菱
化成工業製)を充填したカラム(8×60cm)に付
し、3 lのイオン交換水で洗浄後、50%アセトン水
5 lで溶出し、300mlずつ分画した。溶出画分中
のMer‐WF5027−II物質をペーパーディスク
法による抗菌活性測定(検定菌キャンディダ・アルビカ
ンス)で検出した。抗真菌活性を示すフラクション3〜
7を集め、約1/2に濃縮し、含まれるアセトンを除去
した。これ以降の操作は特に断わらないかぎり、10℃
の低温下で行なった。次に、上記濃縮全量(約1 l)
をQAE-セファデックスカラム(ファルマシア社製;
A-25、Cl型、3.5×60cm)に付した。400
mlのイオン交換水で洗浄し、通過液及びこの洗浄液を
合わせた。Mer−WF5027−II物質はこの画分
に含まれる。この画分をダイアイオンCHP−20(三
菱化成工業製)を充填したカラム(2.5×25cm)
に付し、50% アセトン水で溶出した。抗菌活性区分
を集め、濃縮乾固した。クロロホルム:メタノール(1
00:1)溶液で充填したシリカカラム(和光純薬社
製:C−200,1.8×25cm)に上記濃縮乾固物
をクロロホルム:メタノール(25:1)溶液 3ml
に溶解し吸着させた。つぎにこのカラムをクロロホル
ム:メタノール(100:1)溶液で溶出した。10g
ずつ分画し、活性区分を抗菌活性及びシリカ薄層クロマ
ト(メルク社製:Art.5715,展開溶媒:クロロ
ホルム:メタノール=20:1、検出:紫外部吸収25
4nm)で検出し、フラクション15〜21を集め、濃
縮乾固し43mgのMer−WF5027−II物質を
得た。
The filtrate was applied to a column (8 × 60 cm) packed with Diaion HP-20 (manufactured by Mitsubishi Kasei Kogyo Co., Ltd.), washed with 3 l of ion-exchanged water, and eluted with 5 l of 50% acetone water. Each 300 ml was fractionated. The Mer-WF5027-II substance in the eluted fraction was detected by antibacterial activity measurement (Candida albicans) using a paper disk method. Fraction 3 showing antifungal activity
7 was collected and concentrated to about 1/2 to remove the contained acetone. Unless otherwise specified, the subsequent operations are at 10 ° C.
At low temperature. Next, the above total concentration (about 1 l)
To a QAE-Sephadex column (Pharmacia);
A-25, Cl type, 3.5 × 60 cm). 400
After washing with ml of ion-exchanged water, the flow-through solution and this washing solution were combined. Mer-WF5027-II material is included in this fraction. A column (2.5 × 25 cm) packed with this fraction is packed with Diaion CHP-20 (manufactured by Mitsubishi Kasei Kogyo).
And eluted with 50% acetone water. Antimicrobial activity fractions were collected and concentrated to dryness. Chloroform: methanol (1
00: 1) 3 ml of a chloroform: methanol (25: 1) solution of the above concentrated and dried solid substance was placed on a silica column (Wako Pure Chemical Industries, Ltd .: C-200, 1.8 × 25 cm) packed with a solution.
Dissolved and adsorbed. Next, this column was eluted with a chloroform: methanol (100: 1) solution. 10g
The active components were classified into antibacterial activities and silica thin-layer chromatography (Merck: Art. 5715, developing solvent: chloroform: methanol = 20: 1, detection: ultraviolet absorption 25).
4 nm), and fractions 15 to 21 were collected and concentrated to dryness to obtain 43 mg of Mer-WF5027-II substance.

【0028】かくして得られた抗真菌性物質Mer−W
F5027−IIは次のような理化学的性質を有する。
The antifungal substance Mer-W thus obtained
F5027-II has the following physicochemical properties.

【0029】(1) 色及び性状:淡黄色油状物質 (2) 分子式:C16244 (3) マススペクトル(FAB−MS、マトリックス;
m−ニトロベンジルアルコール):ポジティブ;m/z
303[(M+Na)+],281[(M+H)+] ネガティブ;m/z279[(M−H)-] (4) 比旋光度:[a]D 25=+54.0°(c0.2
2,クロロホルム) (5) 紫外部吸収スペクトル(MeOH) 第1図に示
す λmax nm(ε) [MeOH]:304.8(2
350),254.8(6330) [acidic MeOH]307.0(2130),
254.6(6510) [basic MeOH]:286.4(sh)(38
00),256.4(6120) (6) 赤外部吸収スペクトル(浸透KBr錠剤法) 第
2図に示す 主要な吸収ピーク(cm-1):3385(br),29
55,2930,2857,1732,1645,15
91,1462,1424,1381,1304,12
90,1235,1204,1175,1140,10
73,1040,986,920 (7) 1H−NMRスペクトル(400MHz,CDC
) 第3図に示す 主要なピーク δTMS(ppm):0.89(6H,
t,J=6.6),1.30(16H,m),1.56
(4H,m),1.68(1H,br m),1.83
(2H,m),2.01(1H,br s),2.38
(2H,m),2.50(2H,m),2.65(2H,
m),3.74(2H,br m),3.83(2H,b
r s),4.06(1H,dd,J=12.8,5.
5),4.09(1H,dd,J=12.8,5.5),
4.84(1H,quint.,J=2.2), 4.9
7(1H,td,J=3.7,1.5),5.36(1
H,dd,J=10.3,2.6),5.38(1H,d
d,J=9.9,3.7),6.56(1H,dd,J=
10.3,2.2),6.60(1H,d,J=9.9) (8) 13C−NMRスペクトル(100MHz,CDC
3)第4図に示す 主要なピーク δTMS(ppm):195.0s,1
94.8s,173.6s,172.9s,119.4d,
119.3d,115.4d,113.9d,109.0
s,108.4s,81.1d,80.9d,74.7d,
73.3d,70.8d,31.8t,31.7t,31.
5t,29.2t,29.1t,28.8t,27.0t,
26.9t,25.6t,25.4t,22.5t,14.
0q 信号の多重性に関するデータはDEPT試験によって得
た。
(1) Color and properties: pale yellow oily substance (2) Molecular formula: C 16 H 24 O 4 (3) Mass spectrum (FAB-MS, matrix;
m-nitrobenzyl alcohol): positive; m / z
303 [(M + Na) + ], 281 [(M + H) + ] negative; m / z 279 [(M−H) ] (4) Specific rotation: [a] D 25 = + 54.0 ° (c 0.2
2, chloroform) (5) Ultraviolet absorption spectrum (MeOH) λmax nm (ε) [MeOH] shown in FIG. 1: 304.8 (2
350), 254.8 (6330) [acidic MeOH] 307.0 (2130),
254.6 (6510) [basic MeOH]: 286.4 (sh) (38
00), 256.4 (6120) (6) Infrared absorption spectrum (penetration KBr tablet method) Main absorption peak (cm -1 ) shown in FIG. 2: 3385 (br), 29
55, 2930, 2857, 1732, 1645, 15
91, 1462, 1424, 1381, 1304, 12
90,1235,1204,1175,1140,10
73, 1040, 986, 920 (7) 1 H-NMR spectrum (400 MHz, CDC
l 3 ) Main peak shown in FIG. 3 δTMS (ppm): 0.89 (6H,
t, J = 6.6), 1.30 (16H, m), 1.56
(4H, m), 1.68 (1H, br m), 1.83
(2H, m), 2.01 (1H, brs), 2.38
(2H, m), 2.50 (2H, m), 2.65 (2H,
m), 3.74 (2H, br m), 3.83 (2H, b
rs), 4.06 (1H, dd, J = 12.8, 5.
5), 4.09 (1H, dd, J = 12.8, 5.5),
4.84 (1H, quint., J = 2.2), 4.9
7 (1H, td, J = 3.7, 1.5), 5.36 (1
H, dd, J = 10.3, 2.6), 5.38 (1H, d
d, J = 9.9, 3.7), 6.56 (1H, dd, J =
10.3, 2.2), 6.60 (1H, d, J = 9.9) (8) 13 C-NMR spectrum (100 MHz, CDC
l 3 ) Main peak shown in FIG. 4 δTMS (ppm): 195.0 s, 1
94.8s, 173.6s, 172.9s, 119.4d,
119.3d, 115.4d, 113.9d, 109.0
s, 108.4s, 81.1d, 80.9d, 74.7d,
73.3d, 70.8d, 31.8t, 31.7t, 31.
5t, 29.2t, 29.1t, 28.8t, 27.0t,
26.9t, 25.6t, 25.4t, 22.5t, 14.
Data on the multiplicity of the 0q signal was obtained by the DEPT test.

【0030】(9) 溶解性:酢酸エチル、クロロホル
ム、トルエン、メタノールに溶ける。水に溶けない。
(9) Solubility: soluble in ethyl acetate, chloroform, toluene and methanol. Does not dissolve in water.

【0031】(10) 薄層クロマトグラフィー第5図に
示す メルク社製シリカゲルプレートArt.5715使用、
リンモリブデン酸発色Rf値は次の通り 展開溶媒系 Mer−WF5027−IIA Mer−WF5027−IIB 酢酸エチル 0.7 0.5 クロロホルム: メタノール(20:1) 0.4 0.3 (11) 高速液体クロマトグラフィー 第6図に示す 測定条件は次のとおり カラム:YMC−Pack A−312ODS(6φ×
150mm) カラム温度:20〜25℃の一定温度 移動相:80%(v/v)メタノール/0.02Mリン
酸緩衝液(pH6.8) 流速:1.0ml/min 検出:UV254nm 保持時間は次のとおり Mer−WF5027−IIB:5.0分 Mer−WF5027−IIA:5.7分 存在比は次のとおり Mer−WF5027−IIA:Mer−WF5027
−IIB≒5:1(モル比)
(10) Thin-layer chromatography As shown in FIG. 5, silica gel plate Art. 5715 used,
Phosphomolybdic acid color development Rf value is as follows: developing solvent system Mer-WF5027-IIA Mer-WF5027-IIB ethyl acetate 0.7 0.5 chloroform: methanol (20: 1) 0.4 0.3 (11) High-speed liquid Chromatography The measurement conditions shown in FIG. 6 are as follows. Column: YMC-Pack A-312 ODS (6φ ×
Column temperature: constant temperature of 20 to 25 ° C. Mobile phase: 80% (v / v) methanol / 0.02 M phosphate buffer (pH 6.8) Flow rate: 1.0 ml / min Detection: UV 254 nm Mer-WF5027-IIB: 5.0 min Mer-WF5027-IIA: 5.7 min The abundance ratio is as follows Mer-WF5027-IIA: Mer-WF5027
-IIB ≒ 5: 1 (molar ratio)

【図面の簡単な説明】[Brief description of the drawings]

【図1】図1は抗真菌性物質Mer−WF5027−I
Iのメタノール中(実線)、酸性メタノール中(点
線)、塩基性メタノール中(波線)での紫外部吸収スペ
クトルを示す。
FIG. 1 shows the antifungal substance Mer-WF5027-I.
The ultraviolet absorption spectrum of I in methanol (solid line), acidic methanol (dotted line), and basic methanol (dashed line) is shown.

【図2】図2は抗真菌性物質Mer−WF5027−I
Iの浸透臭化カリウム錠剤法での赤外吸収スペクトルを
示す。
FIG. 2 shows the antifungal substance Mer-WF5027-I.
1 shows the infrared absorption spectrum of I in the osmotic potassium bromide tablet method.

【図3】図3は抗真菌性物質Mer−WF5027−I
Iの重クロロホルム中での400MHz1H−NMRス
ペクトルを示す。
FIG. 3 shows the antifungal substance Mer-WF5027-I.
1 shows a 400 MHz 1 H-NMR spectrum of I in deuterated chloroform.

【図4】図4は抗真菌性物質Mer−WF5027−I
Iの重クロロホルム中での100MHz13C−NMRス
ペクトルを示す。
FIG. 4 shows the antifungal substance Mer-WF5027-I.
1 shows a 100 MHz 13 C-NMR spectrum of I in deuterated chloroform.

【図5】図5は抗真菌性物質Mer−WF5027−I
Iの薄層クロマトグラフを示す。
FIG. 5 shows the antifungal substance Mer-WF5027-I.
1 shows a thin layer chromatograph of I.

【図6】図6は抗真菌性物質Mer−WF5027−I
Iの高速液体クロマトグラフを示す。
FIG. 6 shows the antifungal substance Mer-WF5027-I.
1 shows a high performance liquid chromatograph of I.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI //(C12P 17/06 C12R 1:66) (72)発明者 吉岡 武男 神奈川県綾瀬市上土棚1959 グリーンハ イツ3−3102 (72)発明者 熊本 俊彦 神奈川県藤沢市鵠沼桜が岡1−9−12 (72)発明者 西田 浩史 神奈川県横須賀市津久井568 グリーン ハイツ11−3−503 (72)発明者 岡本 六郎 神奈川県藤沢市花の木2−18 (58)調査した分野(Int.Cl.7,DB名) C07D 311/74 C12P 17/00 - 17/08 CA(STN) REGISTRY(STN) WPI(DIALOG) BIOSIS(DIALOG)──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI // (C12P 17/06 C12R 1:66) (72) Inventor Takeo Yoshioka 1959 Kamizuna, Ayase City, Kanagawa Prefecture Green Heights 3-3102 (72 Inventor Toshihiko Kumamoto 1-9-12 Kugenuma Sakuragaoka, Fujisawa City, Kanagawa Prefecture (72) Inventor Hiroshi Nishida 568, Tsukui, Yokosuka City, Kanagawa Prefecture Green Heights 11-3-503 (72) Inventor Rokuro Okamoto 2-18 Flower Tree, Fujisawa City, Kanagawa Prefecture (58) Fields investigated (Int. Cl. 7 , DB name) C07D 311/74 C12P 17/00-17/08 CA (STN) REGISTRY (STN) WPI (DIALOG) BIOSIS (DIALOG)

Claims (4)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 式 【化1】 で示される抗真菌性物質Mer‐WF5027−II
A。
(1) Formula (1) An antifungal substance Mer-WF5027-II represented by
A.
【請求項2】 式 【化2】 で示される抗真菌性物質Mer−WF5027−II
B。
2. The formula: An antifungal substance Mer-WF5027-II represented by
B.
【請求項3】 式 【化3】 で示される化合物と式 【化4】 で示される化合物との結合異性体混合物よりなる抗真菌
性物質Mer−WF5027−II。
3. The formula: And a compound represented by the formula: An antifungal substance Mer-WF5027-II consisting of a mixture of the binding isomers with the compound represented by the formula:
【請求項4】 アスペルギルス属に属し且つ式 【化1】 で示される抗真菌性物質Mer−WF5027−IIA
及び/又は式 【化2】 で示される抗真菌性物質Mer−WF5027−IIB
を生産する能力を有する菌株を培地で培養し、培養物か
ら抗真菌性物質Mer−WF5027−IIA及び/又
は−IIBを採取することを特徴とする上記式(I)及
び/又は(II)で示される抗真菌性物質Mer−WF
5027−IIA及び/又は−IIBの製造方法。
4. A compound belonging to the genus Aspergillus and having the formula: An antifungal substance Mer-WF5027-IIA represented by
And / or the formula An antifungal substance Mer-WF5027-IIB represented by
A strain having the ability to produce E. coli is cultured in a medium, and the antifungal substances Mer-WF5027-IIA and / or -IIB are collected from the culture, and the above formula (I) and / or (II) is used. Antifungal substance shown Mer-WF
Method for producing 5027-IIA and / or -IIB.
JP20611491A 1991-07-24 1991-07-24 Antifungal substance Mer-WF5027-II Expired - Fee Related JP3064532B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20611491A JP3064532B2 (en) 1991-07-24 1991-07-24 Antifungal substance Mer-WF5027-II

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20611491A JP3064532B2 (en) 1991-07-24 1991-07-24 Antifungal substance Mer-WF5027-II

Publications (2)

Publication Number Publication Date
JPH0525160A JPH0525160A (en) 1993-02-02
JP3064532B2 true JP3064532B2 (en) 2000-07-12

Family

ID=16518033

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20611491A Expired - Fee Related JP3064532B2 (en) 1991-07-24 1991-07-24 Antifungal substance Mer-WF5027-II

Country Status (1)

Country Link
JP (1) JP3064532B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004139792A (en) 2002-10-16 2004-05-13 Toshiba Corp Resistor for electron gun structure, electron gun structure equipped with the same and cathode-ray tube device
CN109553600B (en) * 2018-12-04 2020-11-24 海南师范大学 Isocoumarin compound in mangrove endophytic fungi and preparation method and application thereof

Also Published As

Publication number Publication date
JPH0525160A (en) 1993-02-02

Similar Documents

Publication Publication Date Title
US4530835A (en) CL-1577 Antibiotic compounds and their production
CN101720772B (en) Macrolide composition for preventing and controlling fungal disease of crop and preparation process thereof
EP0371509B1 (en) Antibiotics and process for producing them
EP0185456B1 (en) Cl-1577d and cl-1577e antibiotic/antitumor compounds, their production and use
CN101720781A (en) New phosphorus and nitrogen mycin A for preventing and controlling fungal disease of crop and preparation process thereof
JP3064532B2 (en) Antifungal substance Mer-WF5027-II
US6121310A (en) Aflatoxin contamination inhibitor and aflatoxin contamination-inhibiting method
US5516686A (en) Fungicidal antibiotic producing Streptomyces sp. NCIMB 40212
CN100465188C (en) Novel antibiotic Chemomycin A, B, C, D and preparation method thereof
JP2764759B2 (en) Novel substance BT-38 substance, method for producing the same and antifungal agent containing the same as an active ingredient
JPH05170749A (en) Cyclic depsipeptide and production thereof
JP2955395B2 (en) Antifungal substance Mer-WF5027 and method for producing the same
JPH0616691A (en) Production of 3-deacylated 16-membered ring macrolide antibiotic substance, microorganism to be used therefor and new macrolide antibiotic substance
JPH06234784A (en) New antibiotic sf 2768 substance and its production
US5196327A (en) Process for producing antifungal fermentation products and compositions thereof
JPH0367077B2 (en)
KR790001573B1 (en) Process for preparing alkylated derivatives of antibiotic bm 123
EP0234431A2 (en) 5-Hydroxydihydrofusarubin, a process for its preparation and its use for the preparation of a medicament
JP2990628B2 (en) New plant growth regulating substance aji-302 and its production
JPH0196189A (en) Novel antibiotic sf2446a2 substance, sf2446a3 substance, sf2446 b1 substance, sf2446b2 substance and sf2446b3 substance
JPS5932120B2 (en) Method for producing 9-β-D arabinofuranosyl adenine
JPH0633301B2 (en) Novel antibiotics SF2695A substance and SF2695B substance and method for producing the same
JPH0662632B2 (en) Novel antibiotic A1-R2397 substance and its production method
WO2001064700A1 (en) Novel macrolide compound jk
JPH05155876A (en) Novel antibiotics: mer-af1032a and mer-af1032b

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees